Published in Cancer on December 01, 1962
Chemopreventive effect of bacoside A on N-nitrosodiethylamine-induced hepatocarcinogenesis in rats. J Cancer Res Clin Oncol (2009) 0.84
The role of two enzymes (LDH and PHI) and a tumour marker (CEA) in the prognostic evalution of head and neck malignancy. Indian J Otolaryngol Head Neck Surg (2001) 0.75
Effect of large doses of aureomycin on human liver. AMA Arch Intern Med (1951) 1.58
Pleural-fluid eosinophilia. N Engl J Med (1950) 1.48
Obstructive jaundice as a complication of pancreatis. Ann Intern Med (1963) 1.34
Lactic dehydrogenase activity in human serum. J Lab Clin Med (1956) 1.28
Pharmaceutics of penicillin. J Pharm Sci (1962) 1.24
Cutaneous neurofibromatosis (Von Recklinghausen's disease); clinical manifestation and incidence of sarcoma in sixty-one male patients. AMA Arch Surg (1952) 1.22
The demonstration of the L.E. phenomenon in patients with penicillin hypersensitivity. Blood (1953) 1.20
Pulmonary hemosiderosis and glomerulonephritis. Ann Intern Med (1962) 1.17
Hepatic involvement in extrapulmonary tuberculosis; histologic and functional characteristics. Am J Med (1959) 1.14
Altered liver function of chronic congestive heart failure. Am J Med (1952) 1.13
Serum enzymes in disease. IX. Analysis of factors responsible for elevated values in infectious mononucleosis. Am J Med (1962) 1.13
Effect of large doses of aureomycin, terramycin, and chloramphenicol on livers of mice and dogs. AMA Arch Intern Med (1951) 1.13
THE METABOLIC FATE OF C14-LABELED CHLORDIAZEPOXIDE IN MAN, IN THE DOG, AND IN THE RAT. J Pharmacol Exp Ther (1965) 1.09
Toluene diisocyanate; engineering and medical control of exposures in polyurethane foam manufacturing. Am Ind Hyg Assoc Q (1957) 1.08
Glycolytic, citric acid cycle, and hexosemonophosphate shunt enzymes of plasma and erythrocytes in megaloblastic anemia. J Lab Clin Med (1960) 1.03
Hemolytic anemia in patient receiving nitrofurantoin (furadantin). J Am Med Assoc (1956) 1.02
ENZYME ACTIVITY IN SYNOVIAL FLUID. J Lab Clin Med (1963) 1.02
Hepatic hemosiderin deposits. Incidence in 558 biopsies from patients with and without intrinsic hepatic disease. Arch Intern Med (1961) 1.01
Malignant melanoma; treatment and end-results in two hundred and twenty-five cases. AMA Arch Surg (1954) 0.98
Lactic dehydrogenase and glutamic oxaloacetic transaminase in normal pregnant women and newborn children. Am J Med Sci (1958) 0.96
EFFECTS OF CARBON TETRACHLORIDE POISONING ON THE PLASMA LEVELS OF CYTOPLASMIC AND MITOCHONDRIAL ENZYMES IN ANIMALS WITH NUTRITIONAL FATTY METAMORPHOSIS. J Lab Clin Med (1965) 0.95
LIPOFUSCIN-LIKE GRANULES IN VASCULAR SMOOTH MUSCLE AND JUXTAGLOMERULAR CELLS OF HUMAN KIDNEYS. Am J Pathol (1965) 0.93
The L.E.-cell phenomenon in chronic hepatic disease. N Engl J Med (1956) 0.93
Evaluation of the adequacy of needle-biopsy specimens of the kidney: an autopsy study. Arch Intern Med (1959) 0.93
Hageman factor (HF) deficiency. Blood (1956) 0.92
Antigenicity of connective tissue extracts. Proc Soc Exp Biol Med (1959) 0.92
Apparent hepatic dysfunction in lupus erythematosus. AMA Arch Intern Med (1955) 0.92
Serum enzymes in disease. I. Lactic dehydrogenase and glutamic oxalacetic transaminase in carcinoma. AMA Arch Intern Med (1958) 0.91
MECHANISM OF DEGRADATION OF PENICILLIN G IN ACIDIC SOLUTION. J Pharm Sci (1965) 0.90
Enzymes in anemia: a study of abnormalities of several enzymes of carbohvdrate metabolism in the plasma and erythrocytes in patients with anemia, with preliminary observations of boen marrow enzymes. Ann Intern Med (1960) 0.89
Serum enzymes in disease. VII. Significance of abnormal serum enzyme levels in cardiac failure. Am J Med Sci (1961) 0.89
Serum enzymes in disease. II. Lactic dehydrogenase and glutamic oxalacetic transaminase in anemia. AMA Arch Intern Med (1958) 0.88
Hepatic function in multiple myeloma. J Lab Clin Med (1955) 0.87
Serum enzymes in disease. X. Glycolytic and oxidative enzymes and transaminases in patients with carcinoma of the head, neck, and esophagus. Cancer (1962) 0.87
Observations on the source of elevated plasma ammonia levels in hepatic insufficiency. Am J Med Sci (1956) 0.86
Fasting blood sugar in hepatic disease with reference to infrequency of hypoglycemia. AMA Arch Intern Med (1953) 0.86
Production of nucleophagocytosis by rabbit antileukocytic serum. Blood (1953) 0.86
The liver in pneumococcal pneumonia: observations in 94 cases on liver function and jaundice in pneumonia. J Lab Clin Med (1950) 0.85
The pattern of abnormality of liver function in metastatic carcinoma. J Lab Clin Med (1952) 0.85
Extreme hyperglobulinemia in subacute hepatic necrosis. N Engl J Med (1951) 0.84
Nucleophagocytosis; studies on three hundred thirty-six patients. AMA Arch Intern Med (1956) 0.83
The relationship between proteinuria and fatty elements in the urine sediment. Am J Med Sci (1961) 0.82
Factors influencing betaine aldehyde oxidase activity of rat livers. Am J Physiol (1954) 0.82
[On the pharmacology of Valium, a new psychopharmacologic agent on the benzodiazepine series]. Schweiz Med Wochenschr (1963) 0.81
Congenital nonhemolytic jaundice with disease of the central nervous system. Pediatrics (1956) 0.81
Serum enzymes in disease. IV. Lactic dehydrogenase and glutamic oxalacetic transaminase levels in renal disease. J Lab Clin Med (1958) 0.81
PRIMARY CARCINOMA OF THE LIVER; ANALYSIS OF CLINICAL AND BIOCHEMICAL FEATURES OF 80 CASES. Am J Dig Dis (1965) 0.81
Serum enzymes in disease V. Isocitric dehydrogenase, malic dehydrogenase, and glycolytic enzymes in patients with carcinoma of the breast. Cancer (1961) 0.80
Serum enzymes in disease. VI. Glutathione reductase in sera of normal subjects and of patients with various diseases. J Lab Clin Med (1961) 0.80
BILATERAL RENAL CORTICAL NECROSIS, MALIGNANT HYPERTENSION, PROBABLE PITUITARY INSUFFICIENCY, WITH SURVIVAL. Am J Med (1965) 0.80
Further studies on folic acid-ascorbic acid interrelationships in the rat. J Biol Chem (1952) 0.80
Effect of ACTH on responsiveness to insulin. Metabolism (1953) 0.79
A study of the relation between folic acid and tissue ascorbic acid. J Biol Chem (1952) 0.79
CATALYSIS OF PENICILLIN HYDROLYSIS BY CATECHOL AND 3,6-BIS-(DIMETHYLAMINOMETHYL)CATECHOL. J Pharm Sci (1964) 0.79
STABILITY OF METHICILLIN. J Pharm Sci (1965) 0.78
SERUM ENZYMES IN DISEASE. XV. GLYCOLYTIC AND OXIDATIVE ENZYMES AND TRANSAMINASES IN PATIENTS WITH CARCINOMA OF THE KIDNEY, PROSTATE AND URINARY BLADDER. Cancer (1964) 0.78
Monoamine oxidase inhibition by isocarboxazid. J Pharmacol Exp Ther (1962) 0.78
SERUM ENZYMES IN GASTROINTESTINAL DISEASES. Med Clin North Am (1964) 0.78
Serum enzymes in disease. XI. Glycolytic and oxidative enzymes and transaminases in patients with cancer of the lung. Cancer (1962) 0.78
Serum enzymes in disease. XIII. Comparison of glycolytic and oxidative enzyme and transaminase values in benign and malignant effusions with those in serums. Cancer (1963) 0.78
Megaloblastic anemia in alcoholic cirrhosis. AMA Arch Intern Med (1957) 0.78
SERUM ENZYME LEVELS IN THE DIAGNOSIS OF HEPATIC DISEASE. Am J Gastroenterol (1963) 0.78
Serum enzymes: their value in diagnosis and management of surgical diseases. Surg Clin North Am (1962) 0.77
RATE OF INCREASE IN PLASMA LEVELS OF CYTOPLASMIC AND MITOCHONDRIAL ENZYMES IN EXPERIMENTAL CARBON TETRACHLORIDE HEPATOTOXICITY. J Lab Clin Med (1965) 0.77
Prozone phenomenon in the serodiagnosis of syphilis; a clinical study. Am J Med Sci (1949) 0.77
Hepatocellular jaundice as a complication of iproniazid therapy. Arch Intern Med (1960) 0.76
Studies on the liver in diabetes mellitus. II. The significance of fatty metamorphosis and its correlation with insulin sensitivity. J Lab Clin Med (1950) 0.76
SERUM ENZYMES IN THE DIAGNOSIS OF HEPATIC DISEASE. Gastroenterology (1964) 0.76
Some preliminary clinical and biochemical aspects of liver function in patients receiving iproniazid. Ann N Y Acad Sci (1959) 0.76
Serum enzymes in hepatic disease. Med Clin North Am (1959) 0.76
DISORDERS OF BLOOD. III. ANEMIAS OF INFECTION. J Natl Med Assoc (1963) 0.75